{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T14:19:28Z","timestamp":1791123568720,"version":"4.1.0"},"reference-count":44,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2011,1,1]],"date-time":"2011-01-01T00:00:00Z","timestamp":1293840000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Aureliasan GmbH"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2011,1]]},"DOI":"10.1016\/j.bcp.2010.09.025","type":"journal-article","created":{"date-parts":[[2010,10,9]],"date-time":"2010-10-09T08:35:21Z","timestamp":1286613321000},"page":"259-268","source":"Crossref","is-referenced-by-count":100,"title":["Arzanol, a prenylated heterodimeric phloroglucinyl pyrone, inhibits eicosanoid biosynthesis and exhibits anti-inflammatory efficacy in vivo"],"prefix":"10.1016","volume":"81","author":[{"given":"Julia","family":"Bauer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Koeberle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Friederike","family":"Dehm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federica","family":"Pollastro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Appendino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hinnak","family":"Northoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonietta","family":"Rossi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lidia","family":"Sautebin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver","family":"Werz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcp.2010.09.025_bib0005","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1126\/science.294.5548.1871","article-title":"Prostaglandins and leukotrienes: advances in eicosanoid biology","volume":"294","author":"Funk","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.bcp.2010.09.025_bib0010","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/1-4020-5688-5_1","article-title":"Anti-inflammatory drugs in the 21st century","volume":"42","author":"Rainsford","year":"2007","journal-title":"Subcell Biochem"},{"key":"10.1016\/j.bcp.2010.09.025_bib0015","doi-asserted-by":"crossref","first-page":"4274","DOI":"10.2174\/092986709789578178","article-title":"Inhibitors of the microsomal prostaglandin E(2) synthase-1 as alternative to non steroidal anti-inflammatory drugs (NSAIDs) \u2013 a critical review","volume":"16","author":"Koeberle","year":"2009","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.bcp.2010.09.025_bib0020","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/j.1365-2796.2010.02246.x","article-title":"Microsomal prostaglandin E synthase-1 and 5-lipoxygenase: potential drug targets in cancer","volume":"268","author":"Radmark","year":"2010","journal-title":"J Intern Med"},{"key":"10.1016\/j.bcp.2010.09.025_bib0025","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1055\/s-2007-990242","article-title":"Inhibition of 5-lipoxygenase product synthesis by natural compounds of plant origin","volume":"73","author":"Werz","year":"2007","journal-title":"Planta Med"},{"key":"10.1016\/j.bcp.2010.09.025_bib0030","doi-asserted-by":"crossref","first-page":"659","DOI":"10.2174\/092986706776055698","article-title":"Cyclooxygenase inhibitory natural products: current status","volume":"13","author":"Jachak","year":"2006","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.bcp.2010.09.025_bib0035","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1211\/0022357021778600","article-title":"Anti-inflammatory and antioxidant properties of Helichrysum italicum","volume":"54","author":"Sala","year":"2002","journal-title":"J Pharm Pharmacol"},{"key":"10.1016\/j.bcp.2010.09.025_bib0040","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1021\/np060581r","article-title":"Arzanol, an anti-inflammatory and anti-HIV-1 phloroglucinol alpha-Pyrone from Helichrysum italicum ssp. microphyllum","volume":"70","author":"Appendino","year":"2007","journal-title":"J Nat Prod"},{"key":"10.1016\/j.bcp.2010.09.025_bib0045","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/S0924-8579(01)00336-3","article-title":"Effects of Helichrysum italicum extract on growth and enzymatic activity of Staphylococcus aureus","volume":"17","author":"Nostro","year":"2001","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.bcp.2010.09.025_bib0050","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1021\/jf025940c","article-title":"Chemical composition, plant genetic differences, and antifungal activity of the essential oil of Helichrysum italicum G. Don ssp. microphyllum (Willd) Nym","volume":"51","author":"Angioni","year":"2003","journal-title":"J Agric Food Chem"},{"key":"10.1016\/j.bcp.2010.09.025_bib0055","first-page":"125","article-title":"Evaluation of antiherpesvirus-1 and genotoxic activities of Helichrysum italicum extract","volume":"26","author":"Nostro","year":"2003","journal-title":"New Microbiol"},{"key":"10.1016\/j.bcp.2010.09.025_bib0060","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.cbi.2006.11.006","article-title":"Evaluation of the antioxidant and cytotoxic activity of arzanol, a prenylated alpha-pyrone-phloroglucinol etherodimer from Helichrysum italicum subsp.microphyllum","volume":"165","author":"Rosa","year":"2007","journal-title":"Chem Biol Interact"},{"key":"10.1016\/j.bcp.2010.09.025_bib0065","doi-asserted-by":"crossref","first-page":"6816","DOI":"10.1016\/j.bmcl.2007.10.033","article-title":"Substituted phenanthrene imidazoles as potent, selective, and orally active mPGES-1 inhibitors","volume":"17","author":"Cote","year":"2007","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.bcp.2010.09.025_bib0070","doi-asserted-by":"crossref","first-page":"19881","DOI":"10.1073\/pnas.0809120105","article-title":"ERK-mediated regulation of leukotriene biosynthesis by androgens: a molecular basis for gender differences in inflammation and asthma","volume":"105","author":"Pergola","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.bcp.2010.09.025_bib0075","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1096\/fj.02-0815fje","article-title":"Phosphorylation- and stimulus-dependent inhibition of cellular 5-lipoxygenase activity by nonredox-type inhibitors","volume":"17","author":"Fischer","year":"2003","journal-title":"FASEB J"},{"key":"10.1016\/j.bcp.2010.09.025_bib0080","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1182\/blood.V99.3.1044","article-title":"Activation of 5-lipoxygenase by cell stress is calcium independent in human polymorphonuclear leukocytes","volume":"99","author":"Werz","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.bcp.2010.09.025_bib0085","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1016\/S0006-2952(02)01387-4","article-title":"Hyperforin is a dual inhibitor of cyclooxygenase-1 and 5-lipoxygenase","volume":"64","author":"Albert","year":"2002","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.bcp.2010.09.025_bib0090","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1124\/jpet.108.139444","article-title":"Licofelone suppresses prostaglandin E2 formation by interference with the inducible microsomal prostaglandin E2 synthase-1","volume":"326","author":"Koeberle","year":"2008","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.bcp.2010.09.025_bib0095","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/S0007114509992935","article-title":"Ellagic acid inhibits lipopolysaccharide-induced expression of enzymes involved in the synthesis of prostaglandin E2 in human monocytes","author":"Karlsson","year":"2009","journal-title":"Br J Nutr"},{"key":"10.1016\/j.bcp.2010.09.025_bib0100","doi-asserted-by":"crossref","first-page":"6428","DOI":"10.1046\/j.1432-1327.2000.01735.x","article-title":"Coordinate up- and down-regulation of glutathione-dependent prostaglandin E synthase and cyclooxygenase-2 in A549 cells. Inhibition by NS-398 and leukotriene C4","volume":"267","author":"Thoren","year":"2000","journal-title":"Eur J Biochem"},{"key":"10.1016\/j.bcp.2010.09.025_bib0105","doi-asserted-by":"crossref","first-page":"7220","DOI":"10.1073\/pnas.96.13.7220","article-title":"Identification of human prostaglandin E synthase: a microsomal, glutathione-dependent, inducible enzyme, constituting a potential novel drug target","volume":"96","author":"Jakobsson","year":"1999","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.bcp.2010.09.025_bib0110","doi-asserted-by":"crossref","first-page":"2759","DOI":"10.1007\/s00018-009-0078-3","article-title":"Hyperforin is a novel type of 5-lipoxygenase inhibitor with high efficacy in vivo","volume":"66","author":"Feisst","year":"2009","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.bcp.2010.09.025_bib0115","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1124\/jpet.108.143214","article-title":"Myrtucommulone from Myrtus communis exhibits potent anti-inflammatory effectiveness in vivo","volume":"329","author":"Rossi","year":"2009","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.bcp.2010.09.025_bib0120","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/j.pharmthera.2006.05.009","article-title":"Therapeutic options for 5-lipoxygenase inhibitors","volume":"112","author":"Werz","year":"2006","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.bcp.2010.09.025_bib0125","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s11926-008-0008-7","article-title":"Licofelone: the answer to unmet needs in osteoarthritis therapy?","volume":"10","author":"Kulkarni","year":"2008","journal-title":"Curr Rheumatol Rep"},{"key":"10.1016\/j.bcp.2010.09.025_bib0130","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1038\/sj.bjp.0707416","article-title":"The molecular mechanism of the inhibition by licofelone of the biosynthesis of 5-lipoxygenase products","volume":"152","author":"Fischer","year":"2007","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.bcp.2010.09.025_bib0135","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1124\/jpet.109.160663","article-title":"The molecular pharmacology and in vivo activity of 2-(4-chloro-6-(2,3-dimethylphenylamino)pyrimidin-2-ylthio)octanoic acid (YS121), a dual inhibitor of microsomal prostaglandin E2 synthase-1 and 5-lipoxygenase","volume":"332","author":"Koeberle","year":"2010","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.bcp.2010.09.025_bib0140","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1111\/j.1476-5381.2009.00070.x","article-title":"Myrtucommulone, a natural acylphloroglucinol, inhibits microsomal prostaglandin E(2) synthase-1","volume":"156","author":"Koeberle","year":"2009","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.bcp.2010.09.025_bib0145","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1146\/annurev.biochem.69.1.145","article-title":"Cyclooxygenases: structural, cellular, and molecular biology","volume":"69","author":"Smith","year":"2000","journal-title":"Annu Rev Biochem"},{"key":"10.1016\/j.bcp.2010.09.025_bib0150","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.tibs.2007.06.002","article-title":"5-Lipoxygenase: regulation of expression and enzyme activity","volume":"32","author":"Radmark","year":"2007","journal-title":"Trends Biochem Sci"},{"key":"10.1016\/j.bcp.2010.09.025_bib0155","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/0014-5793(83)80672-3","article-title":"Selective inhibition of 5-lipoxygenase by natural compounds isolated from Chinese plants, Artemisia rubripes Nakai","volume":"158","author":"Koshihara","year":"1983","journal-title":"FEBS Lett"},{"key":"10.1016\/j.bcp.2010.09.025_bib0160","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1016\/0006-2952(91)90501-U","article-title":"Inhibition of mammalian 5-lipoxygenase and cyclo-oxygenase by flavonoids and phenolic dietary additives. Relationship to antioxidant activity and to iron ion-reducing ability","volume":"42","author":"Laughton","year":"1991","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.bcp.2010.09.025_bib0165","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/j.bcp.2003.09.040","article-title":"Mechanisms of the influence of magnolol on eicosanoid metabolism in neutrophils","author":"Hsu","year":"2004","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.bcp.2010.09.025_bib0170","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1124\/jpet.105.090720","article-title":"Identification of molecular targets of the oligomeric nonprenylated acylphloroglucinols from Myrtus communis and their implication as anti-inflammatory compounds","volume":"315","author":"Feisst","year":"2005","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.bcp.2010.09.025_bib0175","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1038\/37635","article-title":"Reduced fertility and postischaemic brain injury in mice deficient in cytosolic phospholipase A2","volume":"390","author":"Bonventre","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.bcp.2010.09.025_bib0180","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1038\/384644a0","article-title":"Structural basis for selective inhibition of cyclooxygenase-2 by anti-inflammatory agents","volume":"384","author":"Kurumbail","year":"1996","journal-title":"Nature"},{"key":"10.1016\/j.bcp.2010.09.025_bib0185","doi-asserted-by":"crossref","first-page":"22903","DOI":"10.1074\/jbc.274.33.22903","article-title":"Arachidonic acid oxygenation by COX-1 and COX-2. Mechanisms of catalysis and inhibition","volume":"274","author":"Marnett","year":"1999","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bcp.2010.09.025_bib0190","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S0014-2999(98)00078-8","article-title":"Comparison of cyclooxygenase-1 and -2 inhibitory activities of various nonsteroidal anti-inflammatory drugs using human platelets and synovial cells","volume":"347","author":"Kawai","year":"1998","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.bcp.2010.09.025_bib0195","doi-asserted-by":"crossref","first-page":"16S","DOI":"10.1002\/j.1552-4604.1996.tb00004.x","article-title":"Inhibition of cyclooxygenase-1 and -2 by R(\u2212)- and S(+)-ibuprofen","volume":"36","author":"Boneberg","year":"1996","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.bcp.2010.09.025_bib0200","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1111\/j.1365-2125.2006.02723.x","article-title":"Dose-response in direct comparisons of different doses of aspirin, ibuprofen and paracetamol (acetaminophen) in analgesic studies","volume":"63","author":"McQuay","year":"2007","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.bcp.2010.09.025_bib0205","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1211\/0022357011778070","article-title":"Cyclooxygenase-1 and cyclooxygenase-2 selectivity of non-steroidal anti-inflammatory drugs: investigation using human peripheral monocytes","volume":"53","author":"Kato","year":"2001","journal-title":"J Pharm Pharmacol"},{"key":"10.1016\/j.bcp.2010.09.025_bib0210","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0014-2999(00)00377-0","article-title":"Are the anti-inflammatory effects of dexamethasone responsible for inhibition of the induction of enzymes involved in prostanoid formation in rat carrageenin-induced pleurisy?","volume":"400","author":"Kawamura","year":"2000","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.bcp.2010.09.025_bib0215","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1189\/jlb.1002477","article-title":"5-Lipoxygenase knockout mice exhibit a resistance to pleurisy and lung injury caused by carrageenan","volume":"73","author":"Cuzzocrea","year":"2003","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.bcp.2010.09.025_bib0220","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1006\/phrs.2000.0784","article-title":"Anti-inflammatory drugs: new multitarget compounds to face an old problem. The dual inhibition concept","volume":"43","author":"Celotti","year":"2001","journal-title":"Pharmacol Res"}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295210007549?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295210007549?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,3,31]],"date-time":"2024-03-31T08:12:14Z","timestamp":1711872734000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295210007549"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,1]]},"references-count":44,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011,1]]}},"alternative-id":["S0006295210007549"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2010.09.025","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2011,1]]}}}